Researchers at Aberdeen University in the United Kingdom disclosed that an experimental drug that targets the "build-up of a specific protein in the brain" showed early promise in dramatically slowing the progression of Alzheimer's diease. The BBC
reported:
UK scientists have developed a drug which may halt the progression of Alzheimer's disease.
Trials of the drug, known as rember, in 321 patients showed an 81% difference in rate of mental decline compared with those not taking the treatment.